Veralto Corporation

- The call transcript does not mention any current or planned fundraising through new debt or equity issuance. - The company highlights a strong balance sheet providing flexibility for future opportunities but does not specify any immediate plans to raise capital. - Focus is on deploying capital through strategic acquisitions (In-Situ and GlobalVision) and share repurchases funded by existing resources. - Cost optimization and operational improvements are emphasized rather than external financing. - Board decisions would govern any increase in share repurchase authorization or capital raises in the future.

- Veralto has made approximately $1 billion investments in 2026 through two strategic acquisitions: In-Situ (Water Quality segment) and GlobalVision (PQI segment). - Trojan UV business within Water Quality segment remains active with strong quoting and bidding; bookings now expected to ship largely in Q4 2025, indicating ongoing capital investment there. - No significant changes in municipal capital expenditure (CapEx) are anticipated; the majority of Water Quality business is tied to OpEx cycles, with steady CapEx primarily from Trojan. - Management maintains a disciplined capital allocation approach with a bias toward M&A over share repurchases, finding M&A to be the best driver for long-term value creation. - Cost optimization program launched to improve operating efficiency and productivity, with savings expected to materialize mostly in 2027 and 2028, indirectly supporting strategic investments.

- Veralto expects core sales growth to accelerate as 2026 progresses, supported by steady demand across municipal and industrial markets. - Water Quality segment projects mid-single-digit growth, with stronger growth in municipal wastewater due to recycle, reclaim, and reuse trends. - Industrial markets, including data centers (semiconductor, power, mining), are expected to show mid- to high-single-digit growth. - PQI segment faces some timing and one-off impacts but anticipates steady demand with good growth later in the year, especially in North America. - Pricing improvements and strong execution across businesses and regions support confidence in full-year revenue growth. - High-growth markets showed slight declines early in the year but are expected to stabilize and improve in the second half. - Acquisitions like In-Situ and GlobalVision contribute to growth, complementing organic sales momentum. - Overall, demand patterns are steady with expected improvement into the second half of the year and easier comps in Q4 facilitating growth.

- Full-year adjusted EPS guidance was raised to $4.20 - $4.28 per share, reflecting strong Q1 and momentum. - Core sales growth expected to accelerate as the year progresses. - Cost optimization program initiated to enhance operating efficiency, with significant savings anticipated in 2027 and 2028. - Mid-single-digit core sales growth with 30% to 35% fall-through in margins remains the value creation algorithm. - Share buybacks and M&A activities (notably In-Situ and GlobalVision acquisitions) support growth and margin expansion. - Operating strength driven by strong Q1 order books, pricing at the higher end, and broad execution across businesses and regions. - Demand patterns are steady with confidence in growth backed by about four months of performance data. - PQI margins expected to maintain or improve consistent with long-term incremental margin framework.

- Strong Q1 performance has positively influenced the order book going into April. - High confidence in full-year EPS driven by solid order books and continued strength in demand. - Trojan and UV segment shows strong quoting and bidding activity with a robust order book. - Longer cycle in the Trojan UV business implies bookings now will largely ship in Q4 2025. - Overall demand patterns are steady across regions with near 4 months of activity behind, providing visibility into order momentum. - No material disruptions expected in order patterns; demand remains steady, supporting confidence in guidance.